Pharmaceutical Company Krka With 6 Percent Revenue Growth

Slovenian pharmaceutical company Krka sold EUR 813.9 million worth of products and services in the first nine months of 2012., up 6% compared to the same period last year, and generated EUR 111.5 million of profit. The Krka Company sold EUR 752.3 million worth of products (up 7%) and generated EUR 107.6 million of profit. At the end of September 2012 the Krka Group had 9,267 employees, an increase by 319, or 4%, from the beginning of the year.

Krka Group plans the 2013 sales to grow 6% to EUR 1,202 million, an increase by EUR 68 million from sales expectations for 2012. Investments are planned to amount to EUR 180 million. Of the ongoing investments that will continue into 2013, the largest are the construction of the Notol 2 plant at the Ločna location in Novo mesto, the expansion of chemical production to the location in Krško, and the construction of the new logistics centre with the new solid dosage forms production plant in Krka’s subsidiary Krka-Rus in the Russian Federation. The largest investment project started in 2013 will be the construction of a new water preparation plant in Novo mesto. Both in Slovenia and abroad the number of employees is planned to increase in 2013, together by a total of 6%.